Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trailblazing perspectives on targeting breast cancer stem cells
Juntao Li, Dan Qi, Tze‐chen Hsieh, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107800-107800
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 159
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis
Kun Xu, Runtian Wang, Hui Xie, et al.
Oncogenesis (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 110
Bioactive nanotherapeutic trends to combat triple negative breast cancer
Pallabita Chowdhury, Upasana Ghosh, Kamalika Samanta, et al.
Bioactive Materials (2021) Vol. 6, Iss. 10, pp. 3269-3287
Open Access | Times Cited: 56
Salinomycin as a potent anticancer stem cell agent: State of the art and future directions
Dan Qi, Yunyi Liu, Juan Li, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 3, pp. 1037-1063
Open Access | Times Cited: 54
Emerging role of interactions between tumor angiogenesis and cancer stem cells
Shuai Lv, Yufei Liu, Changheng Xie, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 468-481
Closed Access | Times Cited: 23
EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer
Xiaojie Liu, Mingjing He, Linlin Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Tumor Cell‐Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β‐Oxidation
Jiang Li, Qi‐Dong Xia, Can Di, et al.
Advanced Science (2022) Vol. 10, Iss. 7
Open Access | Times Cited: 23
Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
Kaibo Guo, Yuqian Feng, Xueer Zheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25
Efficient and Discriminative Isolation of Circulating Cancer Stem Cells and Non-Stem-like Circulating Tumor Cells Using a Click-Handle-Loaded M13 Phage-Based Surface
Hui-Da Li, Fei Jia, Xuejun Wang, et al.
Analytical Chemistry (2025)
Closed Access
Increased expression of PD-L1 in endometrial cancer stem-like cells is regulated by hypoxia
Shasha Yin, Yue Guo, Xinyue Wen, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 16
Engineered Leukocyte Biomimetic Colorimetric Sensor Enables High-Efficient Detection of Tumor Cells Based on Bioorthogonal Chemistry
Min Li, Lanlan Jia, Aihong Zhu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 28, pp. 36106-36116
Closed Access | Times Cited: 3
Inhibition of fucoidan on breast cancer cells and potential enhancement of their sensitivity to chemotherapy by regulating autophagy
Nan Zhang, Meilan Xue, Qing Wang, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6904-6917
Closed Access | Times Cited: 20
Cancer Stem Cells: Biology and Therapeutic Implications
Héctor Mayani, Antonieta Chávez‐González, Karla Vázquez-Santillan, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 770-784
Open Access | Times Cited: 13
Autophagy as a Therapeutic Target in Breast Tumors: The Cancer stem cell perspective
Sana Raza, Jawed A. Siddiqui, Anubhav Srivastava, et al.
Autophagy Reports (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
Zhenxian Xiang, Qiuming He, Li Huang, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 10
Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation
Eunji Kang, Hong‐Kyu Kim, Han‐Byoel Lee, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy
Shu Zhou, OU Hai-long, Yatao Wu, et al.
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108434-108434
Closed Access | Times Cited: 5
Density Gradient Centrifugation is an Effective Tool to Isolate Cancer Stem-Like Cells from Hypoxic and Normoxia Triple-Negative Breast Cancer Models
Camillo Sargiacomo, Aleksandr Klepinin
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8958-8958
Open Access | Times Cited: 1
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
Jing Lu, Ying Zhang, Chunyan Yan, et al.
Bioactive Materials (2024) Vol. 45, pp. 567-583
Closed Access | Times Cited: 1
A Concise Review of Prodigious Salinomycin and Its Derivatives Effective in Treatment of Breast Cancer: (2012–2022)
Viren Soni, Akhil Nagar, Ruchita Bardiya, et al.
International Journal of Translational Medicine (2023) Vol. 3, Iss. 2, pp. 217-245
Open Access | Times Cited: 3
TNFAIP3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway
Wanru Feng, Mengdi Gao, Mao Yang, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 5
Nanotechnological Approaches for the Treatment of Triple-Negative Breast Cancer: A Comprehensive Review
Lahanya Guha, Ishfaq Ahmad Bhat, Aasiya Bashir, et al.
Current Drug Metabolism (2022) Vol. 23, Iss. 10, pp. 781-799
Closed Access | Times Cited: 4
Using dynamic cell communication improves treatment strategies of breast cancer
Zhibo Liu, Song Hu, Zehui Yun, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry
Qian Yang, Qianqian Li, Hua Fan
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access
The feedback loop between MTA1 and MTA3/TRIM21 modulates stemness of breast cancer in response to estrogen
Jingyao Zhang, Yinuo Wang, Jingjing Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access
Page 1 - Next Page

Scroll to top